Feedback / Questions
TP53 R175H-targeting TCR T - Affini-T Therap
AFNT-212 - Affini-T Therap
https://www.businesswire.com/news/home/20240501955728/en/Affini-T-Therapeutics-to-Present-Data-From-Its-Preclinical-Programs-Targeting-KRAS-G12D-and-TP53-R175H-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-27th-Annual-Meeting
May 1, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next